BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9869567)

  • 1. Therapeutic effect of clarithromycin on a transplanted tumor in rats.
    Sassa K; Mizushima Y; Fujishita T; Oosaki R; Kobayashi M
    Antimicrob Agents Chemother; 1999 Jan; 43(1):67-72. PubMed ID: 9869567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.
    Sassa K; Mizushima Y; Kobayashi M
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2787-9. PubMed ID: 10543765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of a new synthetic lipid A analog (ONO-4007) on a tumor implanted at different sites in rats.
    Mizushima Y; Sassa K; Fujishita T; Oosaki R; Kobayashi M
    J Immunother; 1999 Sep; 22(5):401-6. PubMed ID: 10546155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
    Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma.
    Badgwell BD; Valentino DJ; Jeffes EB; Dieffenbach K; Dulkanchainun SB; Yamamoto RS; Granger GA; Jakowatz JG; Carson WE
    Cancer Immunol Immunother; 2003 Jan; 52(1):10-6. PubMed ID: 12536235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells.
    Kuramitsu Y; Nishibe M; Ohiro Y; Matsushita K; Yuan L; Obara M; Kobayashi M; Hosokawa M
    Anticancer Drugs; 1997 Jun; 8(5):500-8. PubMed ID: 9215614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
    Welch DR; Fabra A; Nakajima M
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7678-82. PubMed ID: 2217201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
    Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW; Kuperman O; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor.
    Hoon DS; Ramshaw IA
    Cancer Immunol Immunother; 1985; 20(2):175-8. PubMed ID: 3849980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppression.
    Frey AB; Appleman LJ
    Clin Immunol Immunopathol; 1993 Nov; 69(2):223-33. PubMed ID: 8403560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
    Elizalde PV; Guerra FK; Gravano M; Lanari C; Lippman ME; Charreau EH; Lupu R
    Cancer Invest; 1995; 13(2):173-80. PubMed ID: 7874571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta production and induction of cellular responses in 13762NF rat mammary adenocarcinoma cell clones.
    Kaufmann AM; Stoeck M; Schirrmacher V; Lichtner RB
    Invasion Metastasis; 1993; 13(5):244-52. PubMed ID: 7960577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
    Mizushima Y; Sassa K; Hamazaki T; Fujishita T; Oosaki R; Kobayashi M
    Br J Cancer; 1998 Oct; 78(8):1030-4. PubMed ID: 9792146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma.
    Wang F; Elliott RL; Head JF
    Anticancer Res; 1999; 19(1A):445-50. PubMed ID: 10226580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer.
    Hamada K; Mikasa K; Yunou Y; Kurioka T; Majima T; Narita N; Kita E
    Chemotherapy; 2000; 46(1):49-61. PubMed ID: 10601798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.
    McGary CT; Miele ME; Welch DR
    Am J Pathol; 1995 Dec; 147(6):1668-81. PubMed ID: 7495292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
    Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
    Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta.
    Johansson N; Westermarck J; Leppä S; Häkkinen L; Koivisto L; López-Otín C; Peltonen J; Heino J; Kähäri VM
    Cell Growth Differ; 1997 Feb; 8(2):243-50. PubMed ID: 9040946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
    Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.